Fineline Cube

Follow:
14436 Articles
Policy / Regulatory

NHSA’s 2022 Healthcare Security Report Reveals Break-Even Performance

CompanyDrug

Bio-Thera Solutions Initiates Phase I Study for Trop2-Targeting ADC BAT8008

CompanyDrug

Astellas and Seagen File for NMPA Approval of Enfortumab Vedotin for Urothelial Carcinoma

CompanyDeals

HealiRNA Secures RMB 100 Million in Pre-Series A Funding for Nucleic Acid Drug Development

CompanyDrug

InnoCare Pharma Initiates Clinical Study for BCL2 Inhibitor ICP-248 in China

CompanyDeals

Thederma Pharmaceuticals Raises RMB 100 Million for AhR-Targeted Autoimmune Therapies

CompanyDeals

Xinrui Medtech Secures Pre-Series A Funding for Cardiovascular Device Development

CompanyDrug

Haihe Pharma’s Glumetinib Gains Conditional NMPA Approval for NSCLC

CompanyDeals

AmVision Biotech Secures Nearly $14.34M in Series A+ for Ophthalmology Innovations

CompanyDrug

JW Therapeutics Launches Carteyva Clinical Study for High-Risk Lymphoma

CompanyDeals

Chongqing Evaheart Secures Near $100M in Series A for Heart Failure Platform

CompanyDeals

Biocytogen and Janssen Sign Licensing Agreement for RenLite Platform